Abstract
BACKGROUND: Increasing evidence suggests that enlarged perivascular spaces (ePVS) are associated with cognitive dysfunction in aging. However, the pathogenesis of ePVS remains unknown. Here, we tested the possibility that baseline cerebrovascular dysfunction, as measured by a magnetic resonance imaging measure of cerebrovascular reactivity, contributes to the later development of ePVS. METHODS: Fifty cognitively unimpaired, older adults (31 women; age range, 60–84 years) underwent magnetic resonance imaging scanning at baseline and follow-up separated by ≈2.5 years. ePVS were counted in the basal ganglia, centrum semiovale, midbrain, and hippocampus. Cerebrovascular reactivity, an index of the vasodilatory capacity of cerebral small vessels, was assessed using carbon dioxide inhalation while acquiring blood oxygen level-dependent magnetic resonance images. RESULTS: Low baseline cerebrovascular reactivity values in the basal ganglia were associated with increased follow-up ePVS counts in the basal ganglia after controlling for age, sex, and baseline ePVS values (estimate [SE]=−3.18 [0.96]; P=0.002; [95% CI, −5.11 to −1.24]). This effect remained significant after accounting for self-reported risk factors of cerebral small vessel disease (estimate [SE]=−3.10 [1.00]; P=0.003; [CI, −5.11 to −1.09]) and neuroimaging markers of cerebral small vessel disease (estimate [SE]=−2.72 [0.99]; P=0.009; [CI, −4.71 to −0.73]). CONCLUSIONS: Our results demonstrate that low baseline cerebrovascular reactivity is a risk factor for later development of ePVS.
| Original language | English |
|---|---|
| Pages (from-to) | 2785-2793 |
| Number of pages | 9 |
| Journal | Stroke |
| Volume | 54 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 1 2023 |
Bibliographical note
Publisher Copyright:© 2023 American Heart Association, Inc.
Funding
This work was supported by the National Institutes of Health (NIA P30 AG072946 [Dr Gold], NIA P30 AG028383 - 15S1 [Dr Gold], NIA R01 AG055449 [Dr Gold], NIA R01 AG068055 [Dr Gold], NINDS RF1 NS122028 [Dr Gold], NIBIB P41 EB031771 [Dr Lu], NIA F30 AG079506-01A1 [T.J. Libecap]). T.J. Libecap was also supported by an award from the American Heart Association. The content is solely the responsibility of the authors and does not necessarily represent the official views of these granting agencies.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | |
| National Institute on Aging | R01 AG055449, R01 AG068055, P30 AG028383 - 15S1, P30 AG072946 |
| National Institute on Aging | |
| Institute of Neurological Disorders and Stroke National Advisory Neurological Disorders and Stroke Council | RF1 NS122028 |
| Institute of Neurological Disorders and Stroke National Advisory Neurological Disorders and Stroke Council | |
| National Institute of Biomedical Imaging and Bioengineering | P41 EB031771, F30 AG079506-01A1 |
| National Institute of Biomedical Imaging and Bioengineering | |
| American the American Heart Association |
Keywords
- carbon dioxide
- cerebral small vessel disease
- executive function
- hypercapnia
- magnetic resonance imaging
ASJC Scopus subject areas
- Clinical Neurology
- Cardiology and Cardiovascular Medicine
- Advanced and Specialized Nursing